Sunday, October 18, 2015

Dr. Anderson makes her Editorial Column Debut on Sickle Cell



COMMENT
The far-flung reach of sickle-cell disease
DELAWARE VOICE
DR. NINA ANDERSON

   Sickle-cell disease is a lethal blood disorder that is oftentimes invisible and misunderstood. This debilitating and painful disorder impacts the lives of people who suf- fer from this condition.
Sickle cell most frequently occurs in people who have descended from trop- ical and sub-tropical regions of the world where malaria is prevalent such as, Africa, South and Central America, the Caribbean, the Mediterranean, Asia and the Middle East.
    In fact, sickle cell is one of the world’s most common inherited blood disorders. In 1910, a western physician was the first to note a patient with “sickle shaped” red blood cells. Histori- cally, access to quality specialty care and research tends to lag far behind other chronic diseases and blood dis- orders. Despite the needs to improve health equity, the life expectancy for those living with the disease has im- proved over the last two decades. Yet, the availability of specialty centers for children is four times greater than for adults. In spite of societal burdens for those living with a progressive chronic disease, a person’s quality of life should be considered of high importance. This would include indicators to improve one’s overall (physical, emotional and spiritual) health, educational, and em- ployment opportunities.
    The availability of resources for research and a cure is recognized, but the improvement of a person’s health- care experience in a broader context is not often accepted as a priority.
Other indicators of a population’s health would include access to: nutri- tious foods, parks for walking and bike
paths, policies that lower income dis- parities, affordable housing, high-qual- ity public education, vocational training and gainful employment for persons with disabilities, clean water, culturally competent healthcare providers, qual- ity mental health care and etc. In other words, why not put more resources into initiatives that build healthy patients, families, communities and cities for all which would ultimately benefit those living with sickle cell?
    As National Sickle Cell Awareness Month comes to an end, Tova Community Health wants to thank all those who came out to support raising Sickle Cell Awareness in Delaware. On Sept. 5, Tova Community Health held a fun- filled 5K & 1 Mile Walk/Run with over 500 participants at Brandywine Park in Wilmington. Generations of families, young and old, enjoyed a fantastic day in the park for an unspoken disease. Later in the evening, an awards show
was held at the Christina Cultural Arts Center to honor community leaders for their support and to recognize those living with complex chronic medical conditions.
Tova’s mission is to provide holistic comprehensive compassionate care and awareness to persons living with com- plex chronic diseases like sickle cell. Join us by volunteering, making a dona- tion, supporting our specialty center and outreach events held in the commu- nity. We are that much closer to, “Breaking the Sickle Cycle.” Again, thank you for your generosity and sup- port. If you would like more informa- tion, please visit our website at www.tovacommunityhealth.org.

Dr. Nina Anderson is the executive director of Tova Community Health and is an Affiliated Associate Professor at the University of Delaware.

                                                   The News Journal/Delaware Online
Leslie & Dr. Nina
 
September 25, 2015.  The News Journal 09/25/2015. Copy Reduced from original to fit letter page 
Page : A21

Wednesday, October 14, 2015

A group of scientists call for a Moratorium on Gene Editing

  A group of scientists call for a Moratorium on Gene Editing

The International Society for Stem Cell Research and the  Doudna group calls for public discussion, but is also working to develop some more formal process, such as an international meeting convened by the National Academy of Sciences, to establish guidelines for human use of the genome-editing technique.  A paper published in Science calls for a moratorium on any clinical application.


GMO Corn-debate.org

    Genome engineering technology offers unparalleled potential for modifying human and nonhuman genomes. In humans, it holds the promise of curing genetic disease like sickle cell disease, cystic fibrosis, muscular dystrophy & cancer.   In other organisms, it provides methods to reshape the biosphere for the benefit of the environment and human societies. However, with such enormous opportunities come unknown risks to human health and well-being. In January, a group of interested stakeholders met in Napa, California, to discuss the scientific, medical, legal, and ethical implications of these new prospects for genome biology. The goal was to initiate an informed discussion of the uses of genome engineering technology, and to identify those areas where action is essential to prepare for future developments. The meeting identified immediate steps to take toward ensuring that the application of genome engineering technology is performed safely and ethically.


"Mouse-Ear"-ahsmediacenter.pbworks.com
DOI: 10.1126/science.aab1028.   PERSPECTIVE  BIOTECHNOLOGY
A prudent path forward for genomic engineering and germline gene modification
David Baltimore1, Paul Berg2, Michael Botchan3,4, Dana Carroll5, R. Alta Charo6, George Church7, Jacob E. Corn4, George Q. Daley8,9, Jennifer A. Doudna4,10,*, Marsha Fenner4, Henry T. Greely11, Martin Jinek12, G. Steven Martin13, Edward Penhoet14, Jennifer Puck15, Samuel H. Sternberg16, Jonathan S. Weissman4,17, Keith R. Yamamoto4,18

         Some in the science community urge us to proceed considerately w/ caution. Researchers and the public need to have considerate  debate raising important ethical, safety, regulatory & public policy concerns altering genes.   Though highly efficient, the technique occasionally cuts the genome at unintended sites.   The chief problem has always been one of accuracy, of editing the DNA at precisely the intended site, since any off-target change could be lethal.
        Dr. Baltimore said. “I personally think we are just not smart enough — and won’t be for a very long time — to feel comfortable about the consequences of changing heredity, even in a single individual.”

       I would also suggest that each state's medical and research community set-up a Center for BioEthics to raise these important issues.   Does anyone know the long-term implications of  altering corns' genes and sold to farmers by Genetically Modified Organism (GMO0) companies?

All the best,
Dr. Anderson